AU6000600A - Diagnostic method - Google Patents

Diagnostic method

Info

Publication number
AU6000600A
AU6000600A AU60006/00A AU6000600A AU6000600A AU 6000600 A AU6000600 A AU 6000600A AU 60006/00 A AU60006/00 A AU 60006/00A AU 6000600 A AU6000600 A AU 6000600A AU 6000600 A AU6000600 A AU 6000600A
Authority
AU
Australia
Prior art keywords
diagnostic method
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60006/00A
Inventor
Keith Brown
Karim Malik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9916669.6A external-priority patent/GB9916669D0/en
Priority claimed from GBGB9926293.3A external-priority patent/GB9926293D0/en
Application filed by University of Bristol filed Critical University of Bristol
Publication of AU6000600A publication Critical patent/AU6000600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU60006/00A 1999-07-15 2000-07-17 Diagnostic method Abandoned AU6000600A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9916669 1999-07-15
GBGB9916669.6A GB9916669D0 (en) 1999-07-15 1999-07-15 Diagnostic method
GB9926293 1999-11-05
GBGB9926293.3A GB9926293D0 (en) 1999-11-05 1999-11-05 Diagnostic method
PCT/GB2000/002741 WO2001006005A2 (en) 1999-07-15 2000-07-17 Diagnostic method comprising wt1 sequences

Publications (1)

Publication Number Publication Date
AU6000600A true AU6000600A (en) 2001-02-05

Family

ID=26315771

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60006/00A Abandoned AU6000600A (en) 1999-07-15 2000-07-17 Diagnostic method

Country Status (4)

Country Link
EP (1) EP1200623A2 (en)
JP (1) JP2003505035A (en)
AU (1) AU6000600A (en)
WO (1) WO2001006005A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE347619T1 (en) * 2000-08-25 2006-12-15 Lovelace Respiratory Res Inst METHOD FOR CANCER DETECTION USING NESTED (ßNESTEDß) METHYLATION-SPECIFIC PCR
US20030211522A1 (en) * 2002-01-18 2003-11-13 Landes Gregory M. Methods for fetal DNA detection and allele quantitation
GB0209776D0 (en) * 2002-04-29 2002-06-05 Univ Bristol Diagnostic method
FR2854903A1 (en) * 2003-05-13 2004-11-19 Centre Nat Rech Scient In vitro diagnosis of cancer, based on detecting hypomethylation of deoxycytidine in CpG doublets present in specific sequences from the B melanoma antigen locus
AU2015318823A1 (en) 2014-09-15 2016-03-24 Garvan Institute Of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3393867B2 (en) * 1989-11-13 2003-04-07 マサチユーセツツ・インステイテユート・オブ・テクノロジー Localization and characterization of the Wilms oncogene
AU8381698A (en) * 1997-07-03 1999-01-25 Case Western Reserve University Compositions and methods for detection of genomic imprinting disorders

Also Published As

Publication number Publication date
WO2001006005A2 (en) 2001-01-25
EP1200623A2 (en) 2002-05-02
JP2003505035A (en) 2003-02-12
WO2001006005A3 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU4784500A (en) Reduction apparatus
AU1854901A (en) Novel method
AU2308900A (en) Analysis method
AU6105199A (en) Diagnostic method
AU1163101A (en) Diagnostic methods
AU5672300A (en) Diagnostic device
AU3191100A (en) Ligand-bonded complex
AU6000600A (en) Diagnostic method
AU2194801A (en) Diagnostic method
AU4416500A (en) Tomographic system
AU4755800A (en) Diagnostic system
AU1984900A (en) Diagnostic method
AUPP612798A0 (en) Diagnostic method
AU6925800A (en) Autogrid analysis
AU5552200A (en) Method
AU1134601A (en) Assay method
AU2188401A (en) Assay method
AU4585100A (en) Method
AUPO933597A0 (en) Diagnostic method
AUPP999499A0 (en) Software diagnostic method
AU1164401A (en) Method
AU1737601A (en) Collectalbum
AUPR072100A0 (en) Diagnostic method
AUPQ288199A0 (en) Diagnostics

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase